Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Chronic granulomatous disease: the European experience.

van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, Español T, Fischer A, Kurenko-Deptuch M, Mouy R, Petropoulou T, Roesler J, Seger R, Stasia MJ, Valerius NH, Weening RS, Wolach B, Roos D, Kuijpers TW.

PLoS One. 2009;4(4):e5234. doi: 10.1371/journal.pone.0005234. Epub 2009 Apr 21.

2.

Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.

Kardos G, Zwaan CM, Kaspers GJ, de-Graaf SS, de Bont ES, Postma A, Bökkerink JP, Weening RS, van der Does-van den Berg A, van Wering ER, Korbijn C, Hählen K.

Leukemia. 2005 Dec;19(12):2063-71.

PMID:
16107896
3.

BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).

Kamps WA, Bökkerink JP, Hakvoort-Cammel FG, Veerman AJ, Weening RS, van Wering ER, van Weerden JF, Hermans J, Slater R, van den Berg E, Kroes WG, van der Does-van den Berg A.

Leukemia. 2002 Jun;16(6):1099-111.

4.

Genetic analysis of patients with leukocyte adhesion deficiency: genomic sequencing reveals otherwise undetectable mutations.

Roos D, Meischl C, de Boer M, Simsek S, Weening RS, Sanal O, Tezcan I, Güngör T, Law SK.

Exp Hematol. 2002 Mar;30(3):252-61.

PMID:
11882363
5.

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.

Eijkhout HW, van Der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA, Strengers PF, Nienhuis H, Schellekens PT; Inter-University Working Party for the Study of Immune Deficiencies.

Ann Intern Med. 2001 Aug 7;135(3):165-74.

PMID:
11487483
6.

Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.

Weening RS, De Boer M, Kuijpers TW, Neefjes VM, Hack WW, Roos D.

Clin Exp Immunol. 2000 Dec;122(3):410-7.

7.

Intracellular reactions in single human granulocytes upon phorbol myristate acetate activation using confocal Raman microspectroscopy.

Sijtsema NM, Tibbe AG, Segers-Nolten IG, Verhoeven AJ, Weening RS, Greve J, Otto C.

Biophys J. 2000 May;78(5):2606-13.

8.

A missense mutation in the heavy subunit of gamma-glutamylcysteine synthetase gene causes hemolytic anemia.

Ristoff E, Augustson C, Geissler J, de Rijk T, Carlsson K, Luo JL, Andersson K, Weening RS, van Zwieten R, Larsson A, Roos D.

Blood. 2000 Apr 1;95(7):2193-6.

PMID:
10733484
9.

Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.

Leusen JH, Meischl C, Eppink MH, Hilarius PM, de Boer M, Weening RS, Ahlin A, Sanders L, Goldblatt D, Skopczynska H, Bernatowska E, Palmblad J, Verhoeven AJ, van Berkel WJ, Roos D.

Blood. 2000 Jan 15;95(2):666-73.

PMID:
10627478
10.

Clinical and laboratory work-up of patients with neutrophil shortage or dysfunction.

Kuijpers TW, Weening RS, Roos D.

J Immunol Methods. 1999 Dec 17;232(1-2):211-29. Review.

PMID:
10618522
11.

Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections.

Roos D, van Zwieten R, Wijnen JT, Gómez-Gallego F, de Boer M, Stevens D, Pronk-Admiraal CJ, de Rijk T, van Noorden CJ, Weening RS, Vulliamy TJ, Ploem JE, Mason PJ, Bautista JM, Khan PM, Beutler E.

Blood. 1999 Nov 1;94(9):2955-62.

PMID:
10556177
12.

Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).

Kamps WA, Bökkerink JP, Hählen K, Hermans J, Riehm H, Gadner H, Schrappe M, Slater R, van den Berg-de Ruiter E, Smets LA, de Vaan GA, Weening RS, van Weerden JF, van Wering ER, den der Does-van den Berg A.

Blood. 1999 Aug 15;94(4):1226-36.

PMID:
10438710
13.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) ameliorates chemotherapy-induced neutropenia in children with solid tumors.

van Pelt LJ, de Craen AJ, Langeveld NE, Weening RS.

Pediatr Hematol Oncol. 1997 Nov-Dec;14(6):539-45.

PMID:
9383806
14.

Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins.

Kuijpers TW, Van Lier RA, Hamann D, de Boer M, Thung LY, Weening RS, Verhoeven AJ, Roos D.

J Clin Invest. 1997 Oct 1;100(7):1725-33.

15.

Chronic bullous disease of childhood and a paecilomyces lung infection in chronic granulomatous disease.

Sillevis Smitt JH, Leusen JH, Stas HG, Teeuw AH, Weening RS.

Arch Dis Child. 1997 Aug;77(2):150-2.

16.

Academic pediatrics in the Emma Children's Hospital, Academic Medical Center in Amsterdam (The Netherlands).

Stuve W, Weening RS.

Pediatr Hematol Oncol. 1997 May-Jun;14(3):199-203. Review.

PMID:
9185204
17.

IgG glycation and function during continuous ambulatory peritoneal dialysis.

Davin JC, Bouts AH, Krediet RT, van der Weel M, Weening RS, Groothoff J, Out TA.

Nephrol Dial Transplant. 1997 Feb;12(2):310-4.

PMID:
9132651
18.

Effect of interferon-gamma, in vitro and in vivo, on mRNA levels of phagocyte oxidase components.

Weening RS, de Klein A, de Boer M, Roos D.

J Leukoc Biol. 1996 Dec;60(6):716-20.

PMID:
8975873
19.

The use of rhG-CSF in chronic autoimmune neutropenia: reversal of autoimmune phenomena, a case history.

Kuijpers TW, de Haas M, de Groot CJ, von dem Borne AE, Weening RS.

Br J Haematol. 1996 Sep;94(3):464-9.

PMID:
8790143
20.

A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers.

van Pelt LJ, Huisman MV, Weening RS, von dem Borne AE, Roos D, van Oers RH.

Blood. 1996 Jun 15;87(12):5305-13.

PMID:
8652846
21.

Limitations on the use of dihydrorhodamine 123 for flow cytometric analysis of the neutrophil respiratory burst.

van Pelt LJ, van Zwieten R, Weening RS, Roos D, Verhoeven AJ, Bolscher BG.

J Immunol Methods. 1996 May 27;191(2):187-96.

PMID:
8666838
22.

Increased risk of malignancy for patients with chronic granulomatous disease and its possible link to the pathogenesis of cancer.

Weel EA, Redekop WK, Weening RS.

Eur J Cancer. 1996 Apr;32A(4):734-5. No abstract available.

PMID:
8695282
23.

Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease.

Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, Ahlin A, Nemet K, Hossle JP, Bernatowska-Matuszkiewicz E, Middleton-Price H.

Blood. 1996 Mar 1;87(5):1663-81. Review. No abstract available.

PMID:
8634410
24.

Noonan's syndrome in association with acute leukemia.

Johannes JM, Garcia ER, De Vaan GA, Weening RS.

Pediatr Hematol Oncol. 1995 Nov-Dec;12(6):571-5.

PMID:
8589002
25.

Unexplained recurrent pneumonia: a post-childhood case of chronic granulomatous disease.

Dees A, Weening RS, de Boer M, Baggen MG.

Neth J Med. 1995 Apr;46(4):193-6. Review.

PMID:
7760970
26.

Recombinant human interferon-gamma in patients with chronic granulomatous disease--European follow up study.

Weening RS, Leitz GJ, Seger RA.

Eur J Pediatr. 1995 Apr;154(4):295-8.

PMID:
7607280
27.

[Cyclic neutropenia and treatment with granulocyte colony-stimulating factor (G-CSF)].

Anninga JK, Weening RS.

Ned Tijdschr Geneeskd. 1995 Feb 25;139(8):394-7. Dutch.

PMID:
7885503
28.

156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox.

Leusen JH, Bolscher BG, Hilarius PM, Weening RS, Kaulfersch W, Seger RA, Roos D, Verhoeven AJ.

J Exp Med. 1994 Dec 1;180(6):2329-34.

29.

Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.

Bredius RG, Fijen CA, De Haas M, Kuijper EJ, Weening RS, Van de Winkel JG, Out TA.

Immunology. 1994 Dec;83(4):624-30.

30.

Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children.

Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA.

J Infect Dis. 1994 Oct;170(4):848-53.

PMID:
7930726
31.

A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.

Leusen JH, de Boer M, Bolscher BG, Hilarius PM, Weening RS, Ochs HD, Roos D, Verhoeven AJ.

J Clin Invest. 1994 May;93(5):2120-6.

32.

Developments in pediatric hematology and oncology in The Netherlands.

Weening RS, Zwanenburg H.

Pediatr Hematol Oncol. 1994 Mar-Apr;11(2):141-6. Review. No abstract available.

PMID:
8204439
33.

[Immunodeficiency in The Netherlands: clinical and immunological survey, 1970-1983. Interfacultaire werkgroep Immunodeficiëntie].

Zegers BJ, Weemaes CM, Weening RS, van der Meer JW, Vossen JM.

Ned Tijdschr Geneeskd. 1994 Feb 12;138(7):354-9. Dutch.

PMID:
8121525
34.

Enhanced thrombin generation in children with sickle cell disease.

Peters M, Plaat BE, ten Cate H, Wolters HJ, Weening RS, Brandjes DP.

Thromb Haemost. 1994 Feb;71(2):169-72.

PMID:
8191393
35.

The management of chronic granulomatous disease.

Fischer A, Segal AW, Seger R, Weening RS.

Eur J Pediatr. 1993 Nov;152(11):896-9.

PMID:
8276018
36.

Contribution to scientific research in paediatrics in The Netherlands: evaluation according to subspeciality over a 10-year period.

Verberkmoes JA, Monnens LA, Vossen JM, Weening RS.

Eur J Pediatr. 1993 Nov;152(11):870-2.

PMID:
8276012
37.

Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2.

Bredius RG, de Vries CE, Troelstra A, van Alphen L, Weening RS, van de Winkel JG, Out TA.

J Immunol. 1993 Aug 1;151(3):1463-72.

PMID:
8335940
38.

Colorectal cancer in patients with X-linked agammaglobulinaemia.

van der Meer JW, Weening RS, Schellekens PT, van Munster IP, Nagengast FM.

Lancet. 1993 Jun 5;341(8858):1439-40.

PMID:
8099142
39.

Effector functions of IgG subclass antibodies.

Bredius RG, Van de Winkel JG, Weening RS, Out TA.

Immunodeficiency. 1993;4(1-4):51-3. No abstract available.

PMID:
8167733
40.

Chronic granulomatous disease: mutations in cytochrome b558.

Roos D, De Boer M, De Klein A, Bolscher BG, Weening RS.

Immunodeficiency. 1993;4(1-4):289-301. Review. No abstract available.

PMID:
8167720
41.

A combined immunodeficiency with oligoclonal CD8+, V beta 3-expressing, cytotoxic T lymphocytes in the peripheral blood.

Kuijpers KC, van Dongen JJ, van der Burg P, Roos MT, Vonk J, de Abreu R, de Korte D, van Noesel CJ, Weening RS, van Lier RA.

J Immunol. 1992 Nov 15;149(10):3403-10.

PMID:
1431114
42.
43.
44.

Splice site mutations are a common cause of X-linked chronic granulomatous disease.

de Boer M, Bolscher BG, Dinauer MC, Orkin SH, Smith CI, Ahlin A, Weening RS, Roos D.

Blood. 1992 Sep 15;80(6):1553-8.

PMID:
1520880
45.

Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction.

De Boer M, Bolscher BG, Sijmons RH, Scheffer H, Weening RS, Roos D.

Prenat Diagn. 1992 Sep;12(9):773-7.

PMID:
1438069
46.

The skin in severe combined immunodeficiency: a case with transient cutaneous presence of gamma/delta (TRC1+) T cells.

Sillevis Smitt JH, Weening RS, Krieg SR, Bos JD.

Br J Dermatol. 1992 Sep;127(3):281-5.

PMID:
1327060
47.

[Quantitative and qualitative stock-taking of scientific research in pediatrics in The Netherlands (1986-1990)].

Verberkmoes JA, Monnens LA, Vossen JM, Weening RS.

Tijdschr Kindergeneeskd. 1992 Aug;60(4):98-105. Dutch. Erratum in: Tijdschr Kindergeneeskd 1993 Apr;61(2):68.

PMID:
1440557
48.

[Therapeutic potentials of cytokines and growth factors in severe infections].

van der Meer JW, Weening RS.

Ned Tijdschr Geneeskd. 1992 Jun 13;136(24):1143-7. Review. Dutch. No abstract available.

PMID:
1376858
49.

Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.

Van de Wiel-van Kemenade E, Te Velde AA, De Boer AJ, Weening RS, Fischer A, Borst J, Melief CJ, Figdor CG.

Eur J Immunol. 1992 Jun;22(6):1467-75.

PMID:
1376259
50.

Recombinant human interferon-gamma treatment in severe leucocyte adhesion deficiency.

Weening RS, Bredius RG, Vomberg PP, van der Schoot CE, Hoogerwerf M, Roos D.

Eur J Pediatr. 1992 Feb;151(2):103-7.

PMID:
1537350

Supplemental Content

Loading ...
Support Center